Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01308957 · ClinicalTrials.gov registry record · NA
Fish Oil and Muscle Function
A NA study of Sarcopenia, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
- 1
- Study location
NCT01308957: Completed NA study of Sarcopenia, sponsored by Washington University School of Medicine.
NCT01308957 is a NA study of Sarcopenia that has completed, run by Washington University School of Medicine. The registered enrollment target is 77 participants, roughly in line with the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01308957, a NA study of Sarcopenia, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effect of omega-3 fatty acid supplementation on changes in muscle mass, muscular strength and physical function.
Primary Outcome
We will measure thigh muscle volume by using magnetic resonance imaging. These measurements will also be assessed at week 12 in a subset of subjects but the data will not be used as a primary outcome measure.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Omega-3 fatty acids
- DIETARY_SUPPLEMENT corn oil
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01308957 record still lists
NCT01308957 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, roughly in line with the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target.
The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 2 interventions - of which Omega-3 fatty acids is the first listed.
NCT01308957 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01308957 about?
NCT01308957 is a clinical study titled "Fish Oil and Muscle Function". The purpose of this study is to examine the effect of omega-3 fatty acid supplementation on changes in muscle mass, muscular strength and physical function.
What is the current status of trial NCT01308957?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2011-06. Estimated completion is 2014-12.
What conditions does trial NCT01308957 study?
This clinical trial studies the following conditions: Sarcopenia.
What interventions are being tested in trial NCT01308957?
The interventions under investigation include: Omega-3 fatty acids (DIETARY_SUPPLEMENT), corn oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01308957?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01308957 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01308957's enrollment target sits among peer trials
77 15th of 41 higher than 27 of 41 other Sarcopenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcopenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Spinal Motoneuronal Activation in Older Adults
RECRUITING · NA
-
Strength Training and Resveratrol
RECRUITING · NA
-
Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment
RECRUITING · NA
-
Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)
RECRUITING · NA
-
C-Protein in Fatigue and Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia